Press release
Creative Biolabs Accomplished Its Debut at the Spring PPA Science & Technology Fair
Creative Biolabs participated in the PPA Science & Technology Fair - Spring 2024 as a vendor on May 15, 2024.
New York, USA - May 28, 2024 - The PPA vendor event, held in mid-May, provided an excellent platform for Creative Biolabs to showcase its innovative solutions for antibody development, reinforcing its commitment to supporting scientific research and pharmaceutical advancements. During the hours when the Penn and CHOP communities gathered around to share the latest advancements in scientific research and career opportunities, Creative Biolabs made a significant impact with its new-concept antibody production program.
Image: https://www.getnews.info/uploads/63e81ff884788703b7eb835981dd76ad.png
Highlighting Advanced Antibody Development Platforms
"At the fair, we demonstrated high-throughput hybridoma generation, B-cell sorting, de novo antibody sequencing, and the epitope mapping platform. These state-of-the-art solutions address various challenges in antibody research and development, offering enhanced efficiency and precision." According to one of the scientists who attended the fair that day.
High-Throughput Hybridoma Generation [https://www.creative-biolabs.com/hyperdoma-a-high-throughput-hybridoma-generation-platform.html]
Creative Biolabs' Hyperdoma Trademark platform represents a breakthrough in high-throughput hybridoma generation. Integrating the unique electrofusion system, ClonePix 2 system, fluorometric microvolume assay technology, and Celigo image cytometer, the platform fully utilizes the hybridoma-based antibody discovery that accounts for over 80% of current mAb production, enabling the development and screening of antibodies of superiority. The technology streamlines the development process, enhancing its speed and efficiency.
Image: https://www.getnews.info/uploads/0c59d26f78bf6dd58aafee5bc68d7d8c.jpg
B-Cell Sorting for Precision Antibody Production [https://www.creative-biolabs.com/b-cell-sorting-platform.html]
The B-cell sorting platform was another focal point at the event. This platform leverages advanced techniques like FACS (fluorescent activated cell sorting), LCM (laser-capture microdissection), microengraving, and droplet microfluidics to separate, isolate, and sort single B-cells of integrity and purity, and adopts next-generation sequencing to retrieve native antibodies with extremely high in vivo specificity and affinity. This method significantly enhances the precision and reliability of antibody development, ensuring that researchers can generate antibodies that meet their exact specifications.
Epitope Mapping Platform for Enhanced Research [https://www.creative-biolabs.com/cremap.html]
The Epitope Mapping Platform, known as CreMap Trademark , was showcased as a crucial tool for identifying the precise binding sites of antibodies on their target antigens. This platform enables researchers to map epitopes with high accuracy, facilitating the development of antibodies with enhanced specificity and efficacy, and is particularly important for the creation of targeted therapies and vaccines.
The scientist stated, "Our participation in the PPA Science & Technology Fair underscores our faith in advancing the field of antibody research, particularly in dedicated, enthusiastic communities like Penn. By providing innovative and reliable solutions, we aim to empower researchers to achieve groundbreaking discoveries and develop new therapies."
Creative Biolabs' presence at the fair not only highlighted its cutting-edge technologies, but also reinforced its role as an active practitioner in the antibody development industry. For more information about Creative Biolabs and their services, visit www.creative-biolabs.com [https://www.creative-biolabs.com/].
About
Creative Biolabs is a premier provider of antibody development services, offering a comprehensive range of solutions to support scientific research and pharmaceutical advancements. With a focus on innovation, quality, and customer satisfaction, Creative Biolabs dedicates itself to creating the most individualized projects for researchers with diverse objectives and constantly joins global events to share views and learn about the latest progress in the industry. In 2024, a group of senior scientists from the team will present at the World Bispecific Summit, the Exosome-Based Therapeutic Development Summit, and the World ADC San Diego.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email [http://www.universalpressrelease.com/?pr=creative-biolabs-accomplished-its-debut-at-the-spring-ppa-science-technology-fair]
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com
New York, USA - May 28, 2024 - The PPA vendor event, held in mid-May, provided an excellent platform for Creative Biolabs to showcase its innovative solutions for antibody development, reinforcing its commitment to supporting scientific research and pharmaceutical advancements. During the hours when the Penn and CHOP communities gathered around to share the latest advancements in scientific research and career opportunities, Creative Biolabs made a significant impact with its new-concept antibody production program.
Image: https://www.getnews.info/uploads/63e81ff884788703b7eb835981dd76ad.png
Highlighting Advanced Antibody Development Platforms
"At the fair, we demonstrated high-throughput hybridoma generation, B-cell sorting, de novo antibody sequencing, and the epitope mapping platform. These state-of-the-art solutions address various challenges in antibody research and development, offering enhanced efficiency and precision." According to one of the scientists who attended the fair that day.
High-Throughput Hybridoma Generation [https://www.creative-biolabs.com/hyperdoma-a-high-throughput-hybridoma-generation-platform.html]
Creative Biolabs' Hyperdoma Trademark platform represents a breakthrough in high-throughput hybridoma generation. Integrating the unique electrofusion system, ClonePix 2 system, fluorometric microvolume assay technology, and Celigo image cytometer, the platform fully utilizes the hybridoma-based antibody discovery that accounts for over 80% of current mAb production, enabling the development and screening of antibodies of superiority. The technology streamlines the development process, enhancing its speed and efficiency.
Image: https://www.getnews.info/uploads/0c59d26f78bf6dd58aafee5bc68d7d8c.jpg
B-Cell Sorting for Precision Antibody Production [https://www.creative-biolabs.com/b-cell-sorting-platform.html]
The B-cell sorting platform was another focal point at the event. This platform leverages advanced techniques like FACS (fluorescent activated cell sorting), LCM (laser-capture microdissection), microengraving, and droplet microfluidics to separate, isolate, and sort single B-cells of integrity and purity, and adopts next-generation sequencing to retrieve native antibodies with extremely high in vivo specificity and affinity. This method significantly enhances the precision and reliability of antibody development, ensuring that researchers can generate antibodies that meet their exact specifications.
Epitope Mapping Platform for Enhanced Research [https://www.creative-biolabs.com/cremap.html]
The Epitope Mapping Platform, known as CreMap Trademark , was showcased as a crucial tool for identifying the precise binding sites of antibodies on their target antigens. This platform enables researchers to map epitopes with high accuracy, facilitating the development of antibodies with enhanced specificity and efficacy, and is particularly important for the creation of targeted therapies and vaccines.
The scientist stated, "Our participation in the PPA Science & Technology Fair underscores our faith in advancing the field of antibody research, particularly in dedicated, enthusiastic communities like Penn. By providing innovative and reliable solutions, we aim to empower researchers to achieve groundbreaking discoveries and develop new therapies."
Creative Biolabs' presence at the fair not only highlighted its cutting-edge technologies, but also reinforced its role as an active practitioner in the antibody development industry. For more information about Creative Biolabs and their services, visit www.creative-biolabs.com [https://www.creative-biolabs.com/].
About
Creative Biolabs is a premier provider of antibody development services, offering a comprehensive range of solutions to support scientific research and pharmaceutical advancements. With a focus on innovation, quality, and customer satisfaction, Creative Biolabs dedicates itself to creating the most individualized projects for researchers with diverse objectives and constantly joins global events to share views and learn about the latest progress in the industry. In 2024, a group of senior scientists from the team will present at the World Bispecific Summit, the Exosome-Based Therapeutic Development Summit, and the World ADC San Diego.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email [http://www.universalpressrelease.com/?pr=creative-biolabs-accomplished-its-debut-at-the-spring-ppa-science-technology-fair]
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
